Clinical Trial Update: A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 parallel-group study compared Sativex with placebo for detrusor overactivity in patients with multiple sclerosis; the trial is completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity
• Multiple Sclerosis

Drugs mentioned

• Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Detrusor Overactivity, Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-21